A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap Syndrome

Figure 3

Clinical course of this case. The combination therapy with mPSL and IVCY was effective for improving the renal function of the patient and decreasing the titer of MPO-ANCA in this case. MPO-ANCA is displayed logarithmically. mPSL = methylprednisolone, PSL = prednisolone, and IVCY = intravenous cyclophosphamide.